Skip to main content
IMNM logo

IMNM · Immunome Inc. · Holdings

Track IMNM — free
$16.40 -0.38 (-2.26%)
Market Cap
$1.96B
Shares
118.07M
Volume · Nov 19 854.51K Avg daily vol (3M) 1.35M

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Holders: 212
Total Value: $2,580,031,257
Total Shares: 119,945,672
Showing 1–100 of 217 holdings by value · page 1 of 3

Institutional Ownership Trend

24 quarters

Holder Concentration

Share of 13F common-share value, across 212 filers with any position, options included · Δ vs Jun 30, 2026
Top Holder
16.9%
Dec 2023 → Sep 2026 · range 9.8% – 18.2%
+0.2 pts
Top 5
47.7%
Dec 2023 → Sep 2026 · range 36.0% – 68.9%
+0.1 pts
Top 10
66.0%
Dec 2023 → Sep 2026 · range 61.0% – 89.2%
−0.2 pts
HHI
684
Dec 2023 → Sep 2026 · range 467 – 1,190
Broadly held−1

Who Holds IMNM

Last 8 quarters through Sep 30, 2026

Each kind of 13F filer's share of the common shares 13F filers report. Holder type comes from regulatory records, never the filer's name; style, turnover and horizon are measured from each filer's own 13F book. The quarter selector does not change this card.

Sep 30, 2026: 211 filers, like-for-like change +1.6%; actively managed books +3.3%; index-like books -3.4%.

Holder type Share Filers Change
Registered adviser 33.5% 102 +7.3%
Exempt adviser 1.3% 4 -9.2%
Adviser 17.7% 9 +4.1%
Bank 7.0% 13 -15.1%
Insurer 1.0% 2 -10.4%
Broker-dealer 0.0% 1 +914.3%
Benefit plan 0.2% 5 +9.7%
Non-US 1.7% 8 -1.2%
Holding company 29.5% 7 +1.0%
Unknown 8.1% 60 -2.3%
How the mix is measured

Shares are 13F common shares restated to today's split basis; options and principal amounts are left out. The change compares only filers with a 13F in both quarters and keeps each filer in its bucket of the later quarter on both sides; a filer that continues under a new CIK is compared through its successor. Holder type comes from each filer's current regulatory profile; client base and private funds come from the Form ADV roster current at each quarter end (rosters from December 2019, so an earlier quarter reads Unknown). Style, turnover, horizon and book size are measured from each filer's 13F book in the newest measured quarter, and Not measured means none was. Actively managed books are those measured systematic-like, concentrated or diversified active.

Excluded 2 holders with no observed 2026-06-30 13F and 3 holders with no observed 2026-09-30 13F.

Conviction and Crowding

211 13F filers, quarter ended Sep 30, 2026

Measured across every 13F filer's common-share book once the quarter's filing window closed. Crowding counts filers with high turnover or that advise private funds on Form ADV.

Conviction holders
6
2.84% of filers hold it in their top 10
Jun 30, 2026: 6
Holders above 5%
4
median weight 0.003%
Jun 30, 2026: 4
Crowding
—
holders exceed shares outstanding: 13F filers report more shares than the cover-page count, which predates an issuance, is misstated, or misses shares lent and reported twice
Private-fund advisers
—
of shares outstanding
Institutional ownership
—
holders exceed shares outstanding: 13F filers report more shares than the cover-page count, which predates an issuance, is misstated, or misses shares lent and reported twice
Top 10 holders
66.0%
of 13F shares, Herfindahl 0.068
Active holders
+3.3%
like-for-like share change of active filers
5% stakes on record
6
1 13D, 5 13G (5 institutional, 0 passive, 0 exempt)
How long holders have held it value-weighted 10.2 quarters
Under 1 year 11.3% 1 to 3 years 57.8% 3 years or more 30.9% Since coverage start 0.000%

Managers in the top fifth by current three-year FundScore alpha were net buyers of $78,255,325 (12 buying, 10 selling).

Estimated Holder Cost Basis

Quarter ended Sep 30, 2026, on that quarter's share basis

Estimated, never filed: each 13F buy is costed at its quarter's average traded price and each sale keeps the average cost, so this is what holders paid on average if they traded evenly through each quarter.

Estimated avg cost
$16.35
estimated per share
Jun 30, 2026: $15.67
Quarter-end price
$21.51
implied by 13F values
Estimated gain or loss
+31.5%
price against the estimated cost
Estimated at a loss
13.0%
of costed 13F value

Estimated cost covers 90.8% of the 13F shares; positions already held when a filer's 13F history starts, or bought in a quarter without a trusted average price, have no estimate.

Shared Holders

Companies IMNM's active holders also own, quarter ended Sep 30, 2026
# Company Shared holders
1 ZBIO Zenas BioPharma, Inc. 6
2 ALGS Aligos Therapeutics, Inc. 3
3 IDYA IDEAYA Biosciences, Inc. 7
4 XENE Xenon Pharmaceuticals Inc. 8
5 IBIO iBio, Inc. 4
6 OVID Ovid Therapeutics Inc. 5
7 CAMP Camp4 Therapeutics Corp 4
8 STOK Stoke Therapeutics, Inc. 6
9 IMVT Immunovant, Inc. 6
10 CLDX Celldex Therapeutics, Inc. 7

Shareholder Targets

13F filers that own its peers but not IMNM, quarter ended Sep 30, 2026

Found through its holder-overlap peers: ZBIO, ALGS, IDYA, XENE, IBIO, OVID, CAMP, STOK, IMVT, CLDX, RCUS, DYN, TARS, PRAX, SRRK, EWTX, PTGX, CELC, DFTX, AVTX. 749 filers in all.

# Filer In peers
1 RTW INVESTMENTS, LP Registered adviser, Diversified active $1,508,149,648 6 held
2 FARALLON CAPITAL MANAGEMENT LLC Registered adviser, Diversified active $1,186,548,376 3 held
3 PERCEPTIVE ADVISORS LLC Registered adviser, Diversified active $1,166,342,507 6 held
4 Deep Track Capital, LP Adviser, Diversified active $838,728,990 8 held
5 GILEAD SCIENCES, INC. Unknown, Concentrated $811,701,550 1 held
6 Orbis Allan Gray Ltd Unknown, Diversified active $807,798,591 3 held
7 ORBIMED ADVISORS LLC Registered adviser, Diversified active $749,404,097 6 held
8 Siren, L.L.C. Unknown, Diversified active $747,096,026 6 held
9 DEERFIELD MANAGEMENT COMPANY, L.P. Registered adviser, Diversified active $655,672,946 5 held
10 Avoro Capital Advisors LLC Registered adviser, Concentrated $628,599,321 4 held

Fund Ownership of IMNM by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 14.48% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.06% 3,618,062
Index ETFs 11.41% 13,476,539
Active ETFs 0.41% 488,404
Active funds 30.03% 35,455,664
Unclassified 0.32% 382,756
All registered funds 45.24% 53,421,425
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Quarterly Activity

vs Jun 30, 2026
New
30
Increased
75
Decreased
71
Sold Out
21
Unchanged
34

New and Sold Out count only filers that reported a 13F for both quarters: a first-time filer's book is not a buy, and a fund that has not filed, or withheld its positions under confidential treatment, has not sold.

Holder count: +8
Institutional value: +3.1%
Shares held: +1.6%

Top Buyers

vs Jun 30, 2026
Institution Added Now Holds Open

Top Sellers

vs Jun 30, 2026
Institution Sold Now Holds Open

Top New Positions

vs Jun 30, 2026
Institution Acquired Value (USD) Open

Top Sold-Out Positions

vs Jun 30, 2026
Institution Previously Held Last Value (USD) Open
Showing 100 of 217
Export CSV
Holder Value (USD) % of 13F Shares Own % Change Type Filed Open

Showing the top 100 of 217 holders. Create a free account to see every holder, past quarters, search, filters and CSV export.

Key facts CIK 1472012 CUSIP 45257U108 13F (30d) 216 filings 203 filers Visit website Investor relations